Recursion Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -62.44M-84.61M-186.48M-239.48M-328.07M-463.66M
Depreciation and Depletion 3.50M4.20M8.80M11.40M15.90M18.30M
Share-based Compensation 1.39M4.29M14.84M27.91M53.50M81.69M
Gains from Investment Securities -0.78M-4.10M-0.83M-3.39M-7.58M
Asset Writedowns and Impairment 0.87M2.81M1.19M0.11M
Cash from Operations -57.04M-45.40M-158.61M-83.52M-287.78M-359.17M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 2.49M3.94M8.40M11.76M24.40M36.49M
Change in Working Capital
Change in Receivables 0.03M0.01M-0.11M
Change in Account Payables -0.34M-0.18M1.75M1.77M-0.99M6.43M
Change in Accured Expenses -0.80M4.12M12.76M-0.58M6.72M5.52M
Other Working Capital Changes -0.63M26.67M-10.00M110.32M-41.08M-28.04M
Investing Activities
Capital Expenditures 3.91M5.83M39.80M37.06M11.96M13.70M
Change in Intangibles 0.90M0.30M0.60M3.35M
Acquisitions 2.60M-1.84M-277.10M
Change in Acquisitions & Divestments 0.59M69.19M230.61M0.48M
Cash from Investing Activities -3.91M-8.74M-271.74M193.25M-10.23M260.06M
Financing Activities
Other financing activities 0.28M
Cash from Financing Activities 120.41M246.13M458.54M154.34M140.13M304.12M
Additional items
Exchange Rate Effect -0.31M0.19M-3.41M
Change in Cash 59.46M192.00M28.18M263.76M-157.69M201.60M
Free Cash Flow -60.95M-51.23M-198.41M-120.58M-299.74M-372.87M
Net Cash Flow 59.46M192.00M28.18M264.07M-157.88M205.00M